Research study Program year 2020 Source: CMS Open Payments

Multicentre, Double-blind, Randomized, Parallel Group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus Long-acting Beta2 Agonist BORA

Research payments

$55,217

12 payments

Through program year 2020, $55,217 in research payments was reported against Multicentre, Double-blind, Randomized, Parallel Group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus Long-acting Beta2 Agonist BORA, across 12 payments.

Paid by (largest first)
AstraZeneca Pharmaceuticals LP; AstraZeneca UK Limited
ClinicalTrials.gov
No trial number was reported for this study

By program year

2 rows
Year Kind Amount Payments
2020 Research $131 1
2019 Research $55,086 11

Breakdown

Who paid Research payments · program years 2019–2020
  1. AstraZeneca Pharmaceuticals LP $53,924 9 payments
  2. AstraZeneca UK Limited $1,294 3 payments
Who received the money Research payments · program years 2019–2020
  1. Pediactric Pulmonary And Asthma Associates Organisation paid for research $17,336 1 payment
  2. Advance Medical Research Organisation paid for research $11,651 1 payment
  3. Santiago Reyes Organisation paid for research $7,464 1 payment
  4. The Medical College Of Wisconsin INC Organisation paid for research $5,532 1 payment
  5. Bridge Medical Enrique Davis Md Organisation paid for research $4,925 1 payment
  6. Oklahoma Institute Of Allergy And Asthma Organisation paid for research $3,209 1 payment
  7. Vista Health Research LLC Organisation paid for research $2,128 1 payment
  8. Allergy And Asthma Associates Of Santa Clara Valley Res Center Organisation paid for research $1,387 1 payment
  9. Deborah Gentile Pediatric Allergy/Immunology · Butler, PA $900 1 payment
  10. Duke Raleigh Hospital Organisation paid for research $293 1 payment

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record